The importance of serum biglycan levels as a fibrosis marker in patients with chronic hepatitis B

Novel serological neo-epitope markers of extracellular matrix proteins for the detection of portal hypertension

(2015) D. J. Leeming et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Combined antiretroviral therapy attenuates hepatic extracellular matrix remodeling in HIV patients assessed by novel protein fingerprint markers

(2014) Diana J. Leeming et al.   AIDS

Plasma Pro-C3 (N-terminal type III collagen propeptide) predicts fibrosis progression in patients with chronic hepatitis C

(2014) Mette J. Nielsen et al.   LIVER INTERNATIONAL

Extracellular Matrix Remodeling: The Common Denominator in Connective Tissue DiseasesPossibilities for Evaluation and Current Understanding of the Matrix as More Than a Passive Architecture, but a Key Player in Tissue Failure

(2012) Morten A. Karsdal et al.   ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES

Protein fingerprinting of the extracellular matrix remodelling in a rat model of liver fibrosis-a serological evaluation

(2012) Diana J. Leeming et al.   LIVER INTERNATIONAL

Increased expression of chondroitin sulphate proteoglycans in rat hepatocellular carcinoma tissues

(2012) Xiao-Li Jia   WORLD JOURNAL OF GASTROENTEROLOGY

Deficiency of Biglycan Causes Cardiac Fibroblasts to Differentiate into a Myofibroblast Phenotype

(2011) Ariane Melchior-Becker et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Liver cirrhosis

(2008) Detlef Schuppan et al.   LANCET